Valid

YY/T 1180-2021Typing kit for human leucocyte antigen(HLA) (English PDF)

人类白细胞抗原(HLA)基因分型检测试剂盒

Preview PDF

This is a limited preview

Buy now to download the full PDF (18 pages)

Need quotation for your management?

Get a formal quotation for YY/T 1180-2021 in 30 minutes.

Issued by

NMPA

Level / Type

Industry · Recommended

Issue date

December 6, 2021

Implementation date

May 1, 2023

Scope

YY/T 1180-2021 is the English-translated version of 人类白细胞抗原(HLA)基因分型检测试剂盒.

YY/T 1180-2021 is the Chinese pharmaceutical industry standard for kits that type the human leukocyte antigen (HLA) genes, the test on which donor and recipient are matched before a transplant.

It gives the terms and definitions, the requirements and the test methods, and the rules for identification, labels, instructions for use, packaging, transport and storage.

It covers kits that type HLA class I loci A, B and C and class II loci DRB and DQB, at multi-locus, serological group or allele level, whatever the method: polymerase chain reaction with sequence-specific primers, with sequence-specific oligonucleotide probes, sequence-based typing and others.

It replaces YY/T 1180-2010, was issued on 6 December 2021 and has applied since 1 May 2023.

Found what you need?

Document preview — YY/T 1180-2021

National Standard of the People's Republic of China

Classification
C 44
Replacing
YY/T 1180-2010

Issued by: National Medical Products Administration of the People's Republic of China

Contents

  • Foreword
  • 1 Scope
  • 2 Normative references
  • 3 Terms and Definitions

Foreword

This document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for Standardization Work Part 1. Structure and Drafting Rules of Standardization Documents" drafted.

This document replaces YY/T 1180-2010 "Human Leukocyte Antigen (HLA) Genotyping Kit SSP Method", and YY/T 1180- Compared with:2010, in addition to editorial changes, the main technical changes are as follows:

--- Scope adds the applicable methodology of this document, and examples; adds the inapplicable content of this document (see Chapter 1);

--- Added normative references (see Chapter 2);

--- Added terms and definitions (see 3.3, 3.4);

---The main revisions of technical indicators are as follows:

- Modified the appearance requirements by deleting item c) (see 4.1, 3.1 of the:2010 edition);

- Revised the main performance indicators, which are divided into two categories according to the intended use (see 4.2, 4.3, 3.2~3.7 of the:2010 edition);

- Modified the repeatability requirements (see 4.2.2, 4.3.3, 3.4 of the:2010 edition);

- Revised the effective detection range (see 4.2.3, 3.5 of the:2010 edition);

- Deleted the random failure rate requirement (see 3.6 of the:2010 edition);

- Modified the stability requirements (see 4.2.4, 4.3.5, 3.7 of the:2010 edition);

--- Modified the test method to be compatible with the requirements of Chapter 4 (see Chapter 5, Chapter 4 of the:2010 edition);

--- Modified identification, labels and instructions for use (see Chapter 6, Chapter 5 of the:2010 edition);

--- Modified the packaging, transportation and storage (see Chapter 7, Chapter 6 of the:2010 edition).

1 Scope

This document specifies the terms and definitions, requirements, test methods, standards of human leukocyte antigen (HLA) genotyping test kit products identification, labeling, instructions for use, packaging, transportation and storage, etc.

This document applies to the quality control of human leukocyte antigen (HLA) genotyping detection kits (hereinafter referred to as kits). Should The kit is mainly used for multi-locus, single serological group or allele detection of HLA class I A, B and C sites and class II DRB and DQB.

Genotyping. The kit methodology includes but is not limited to polymerase chain reaction-sequence-specific primer method (PCR-SSP), polymerase chain reaction response-sequence-specific oligonucleotide probe method (PCR-SSO), polymerase chain reaction-gene sequencing typing method (PCR-SBT), fluorescent PCR method, PCR melting curve method, etc. Clinical uses include matching of donor and recipient for transplantation or blood transfusion, auxiliary diagnosis of diseases, etc.

This document does not apply to genotyping kits for the detection of human leukocyte antigen (HLA) using high-throughput sequencing methods.

2 Normative references

The contents of the following documents constitute essential provisions of this document through normative references in the text. Among them, dated citations documents, only the version corresponding to that date applies to this document; for undated references, the latest edition (including all amendments) applies to this document.

GB/T 191 Graphical signs of packaging, storage and transportation

GB/T 29791.2 Information provided by manufacturers of in vitro diagnostic medical devices (labeling) Part 2. In vitro diagnostic reagents for professional use

3 Terms and Definitions

The following terms and definitions apply to this document.

3.1 human leukocyte antigen humanleucocyteantigen; HLA

A group of glycoproteins that play an important role in the body's immune system is encoded by the genome on the short arm of human chromosome 6.

Note: HLA genes are highly genetically polymorphic, with several to hundreds of alleles with different sequences per locus.

3.2 polymerase chain reaction-sequence specific primer method polymerase chain reaction-sequence specific primer; PCR-SSP

A method of amplifying specific HLA alleles by PCR technology using multiple sets of allele-specific primers.

3.3 polymerase chain

reaction-sequence specific oligonucleotide probe method polymerase chain reaction-sequencespecificoligonu- cleotide; PCR-SSO Use isotopically or non-radioactively labeled probes (sequence-specific oligonucleotides) to hybridize to the PCR-amplified target fragment products, according to A method for determining HLA alleles by positive signals.

3.4 polymerase chain reaction-sequence based genotyping; PCR-SBT

Amplify the gene fragment to be analyzed by PCR, and sequence and analyze the DNA sequence to determine the genotype.

......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 18 pages — is available in the English PDF.

Referenced standards

Similar standards

Editions of YY/T 1180

EditionTitleRevisionStatus
YY/T 1180-2021Typing kit for human leucocyte antigen(HLA)current editionCurrent
YY/T 1180-2010Typing kit for human leucocyte antigen(HLA)previous editionSuperseded

This page sells the current edition, YY/T 1180-2021. Earlier editions are listed for reference only.

How to Download YY/T 1180-2021

  1. 1

    Add to cart

    Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.

  2. 2

    Checkout

    Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).

  3. 3

    Fast delivery

    After payment you'll receive an email confirmation. The English PDF is sent to the same address, usually within minutes and at the latest within 1 business day.

  4. 4

    Invoice included

    A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.

Related Standards

English PDF
18 pages
Fast delivery
Invoice included
View Cart

Secure payment via Stripe

Payments accepted

VisaMastercardAmerican ExpressApple PayGoogle PayStripe

YY/T 1180-2021

$105.00